Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDEV.L Regulatory News (DEV)

  • There is currently no data for DEV

Issue of Equity

2 Aug 2019 07:00

RNS Number : 6269H
Dev Clever Holdings PLC
02 August 2019
 

Dev Clever Holdings plc

("Dev Clever" or "the Company")

 

Exercise of warrants

 

Dev Clever, a leading developer of career development and virtual reality careers guidance platforms announces that it has received notice of the exercise of warrants over 2,290,000 ordinary shares of 1 pence each in the share capital of the Company ("Ordinary Shares") at an exercise price of 1 pence per share from Jarvis Investment Management Limited ("Jarvis"). The aggregate gross proceeds of this exercise are £22,900.

 

Following the exercise of these warrants, Jarvis has no further warrants and the number of shares over which other warrants are outstanding is as follows:

 

Number of shares

Exercise price

Expiry date

11,826,264

1.0p

21 January 2024

 

The Company has made application for the 2,290,000 new Ordinary Shares to be admitted to the standard segment of the Official List and to trading on the Main Market of the London Stock Exchange. Admission is expected to occur at 8:00 a.m. on Monday, 5 August 2019. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares.

 

For the purpose of the Disclosure and Transparency Rules, following the admission of 2,290,000 new Ordinary Shares, the Company's total issued ordinary share capital will consist of 375,590,000 Ordinary Shares. The Company holds no ordinary shares in Treasury. As a result, this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

 

 

-Ends -

 

 

For further information please contact:

Dev Clever Holdings plc

 

Christopher Jeffries

CEO, Founder and Executive Chairman 

 

+44 (0) 330 058 2922 

 

Pello Capital - Broker

 

Daniel Gee

+44 (0) 203 700 2534

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOELLFSSTTILIIA
Date   Source Headline
17th Jan 20233:45 pmRNSCancellation of Listing
16th Dec 20227:00 amRNSStatement re Cancellation of Listing and Rebrand
2nd Nov 202212:00 pmRNSTotal Voting Rights
14th Oct 20222:16 pmRNSHolding(s) in Company
14th Oct 20222:15 pmRNSHolding(s) in Company
14th Oct 20222:00 pmRNSExercise of share options and PDMR shareholding
21st Sep 20227:00 amRNSLaunch of Career Success Membership Program
15th Sep 20227:00 amRNSBoard appointment
14th Sep 20223:15 pmRNSResult of Annual General Meeting
31st Aug 202212:30 pmRNSHalf-year Report
31st Aug 20227:00 amRNSBrand Ambassador
22nd Aug 20227:15 amRNSFunding Facility
22nd Aug 20227:00 amRNSAnnual Financial Report
10th Aug 20224:15 pmRNSHolding(s) in Company
3rd Aug 20223:45 pmRNSHolding(s) in Company
2nd Aug 20227:00 amRNSTotal Voting Rights
21st Jul 20229:30 amRNSHolding(s) in Company
20th Jul 20223:00 pmRNSHolding(s) in Company
19th Jul 20223:15 pmRNSHolding(s) in Company
19th Jul 202212:15 pmRNSVeative Acquisition, Trading and Board Updates
19th Jul 202211:45 amRNSAldebaron Partnership Update and Notice of Results
17th May 20224:00 pmRNSDirectorate Change and Notice of Results
28th Apr 20222:50 pmRNSNotice of Final Results Publication
24th Feb 20227:00 amRNSAppointment of Joint Broker
24th Dec 20217:50 amRNSUpdate on Veative acquisition and suspension
21st Dec 20214:41 pmRNSSecond Price Monitoring Extn
21st Dec 20214:36 pmRNSPrice Monitoring Extension
7th Dec 20217:00 amRNSContract
6th Dec 20214:30 pmRNSSenior management appointment
29th Nov 20217:00 amRNSTrading Statement
15th Nov 20217:00 amRNSAppointment
28th Oct 20217:00 amRNSUpdate on Veative Acquisition
18th Oct 20217:00 amRNSCommon Service Centre Update
30th Sep 20217:00 amRNSUpdate on agreement with Veative
2nd Sep 20217:00 amRNSContract
27th Jul 20217:00 amRNSAcquisition
6th Jul 20214:41 pmRNSSecond Price Monitoring Extn
6th Jul 20214:35 pmRNSPrice Monitoring Extension
5th Jul 20217:00 amRNSHalf-year Report
29th Jun 20218:55 amRNSCommon Service Centre Pilot, India
21st Jun 20219:05 amRNSSecond Price Monitoring Extn
21st Jun 20219:00 amRNSPrice Monitoring Extension
21st Jun 20217:15 amRNSTactical partnership and major contract win
21st Jun 20217:00 amRNSProposed acquisition
9th Jun 20217:00 amRNSProgress in India
26th May 20214:40 pmRNSSecond Price Monitoring Extn
26th May 20214:35 pmRNSPrice Monitoring Extension
12th May 20217:00 amRNSExercise of Options
11th May 20214:40 pmRNSSecond Price Monitoring Extn
11th May 20214:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.